Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …
Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
Epidemiology of β-lactamase-producing pathogens
K Bush, PA Bradford - Clinical microbiology reviews, 2020 - Am Soc Microbiol
SUMMARY β-Lactam antibiotics have been widely used as therapeutic agents for the past
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …
Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design
G Bahr, LJ Gonzalez, AJ Vila - Chemical reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …
spread of genes coding for resistance determinants among bacteria challenges the use of …
Advances in the microbiology of Stenotrophomonas maltophilia
JS Brooke - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to
susceptible patient populations. This pathogen can cause nosocomial and community …
susceptible patient populations. This pathogen can cause nosocomial and community …
Clinical challenges treating Stenotrophomonas maltophilia infections: an update
Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …
Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge
Introduction: Stenotrophomonas maltophilia is a prototype of bacteria intrinsically resistant to
antibiotics. The reduced susceptibility of this microorganism to antimicrobials mainly relies …
antibiotics. The reduced susceptibility of this microorganism to antimicrobials mainly relies …
Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies
J Gibb, DW Wong - Antibiotics, 2021 - mdpi.com
Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …
Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: a hospital based study
Y Zhou, X Zhu, H Hou, Y Lu, J Yu, L Mao, L Mao… - BMC infectious …, 2018 - Springer
Background Diarrhea is the leading infectious cause of childhood morbidity and mortality.
Among bacterial agents, diarrheagenic Escherichia coli (DEC) is the major causal agent of …
Among bacterial agents, diarrheagenic Escherichia coli (DEC) is the major causal agent of …
Enteropathogenic Escherichia coli—A Summary of the Literature
Diarrheal disease is still a major public health concern, as it is still considered an important
cause of death in children under five years of age. A few decades ago, the detection of …
cause of death in children under five years of age. A few decades ago, the detection of …